Wells Fargo & Company Senti Biosciences, Inc. Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.36 - $0.66 $1 - $1	3 Added 1.51%	202 $0
Q4 2023 Feb 09, 2024	BUY	$0.28 - $0.68 $2 - $6	10 Added 5.29%	199 $0
Q3 2023 Nov 13, 2023	BUY	$0.41 - $0.99 $20 - $48	49 Added 35.0%	189 $0
Q2 2023 Aug 15, 2023	BUY	$0.6 - $1.14 $4 - $7	7 Added 5.26%	140 $0
Q1 2023 May 12, 2023	BUY	$1.15 - $2.06 $2 - $4	2 Added 1.53%	133 $0
Q4 2022 Feb 13, 2023	SELL	$1.25 - $65.2 $2,821 - $147,156	-2,257 Reduced 94.51%	131 $0
Q3 2022 Nov 14, 2022	BUY	$1.33 - $21.7 $3,176 - $51,819	2,388 New	2,388 $5,000

342K

Ticker SNTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,757,100
Market Cap $172M
Description
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.